Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Not All Health Care Stocks Are Created Equal, So Play It This Way

Published 07/08/2019, 05:30 PM
Updated 05/14/2017, 06:45 AM

Monday's health-care stocks traded lower. Politicians on both sides of the isle have been very critical of drug prices and health-care costs. You can easily see and expect more political criticism of the health-care companies as the Democratic party tries to find a 2020 nominee. President Trump has also vowed to lower drug costs, so where do you invest in this diverse industry group?

Despite Monday's declines in most of the major health-care stocks, the overall chart pattern of the Health Care Select Sector SPDR Fund (NYSE:XLV) is still looking good on the charts. This leading health-care ETF holds companies such as Johnson & Johnson (NYSE:JNJ), Pfizer (NYSE:PFE), UnitedHealth Group (NYSE:UNH), Merck & Company (NYSE:MRK), Abbott Laboratories (NYSE:ABT), Medtronic (NYSE:MDT), Thermo Fisher Scientific (NYSE:TMO), Amgen (NASDAQ:AMGN), AbbVie (NYSE:ABBV) and Eli Lilly (NYSE:LLY). This ETF is fairly diverse and is still showing a decent chart pattern on the bigger time frames. At this point, XLV is trading above its 50- and 200-day moving averages. As long as it remains above these key levels, this ETF continues to be in good shape. If a major decline happens in XLV, there should be major chart support around the $86.00 area. This is where the ETF was defended in mid-April 2019 and would likely be support again if retested.

The bottom line is that health care stocks have become very difficult to trade and invest in on an individual basis lately. The best way to play the broad-based industry group is likely through an ETF like the XLV, which gives you diversity to the sector and holds some of the best companies in the world. Should the equity trade sideways or even lower, it pays a 1.6% dividend while you wait for some appreciation to occur.

Health Care Select Sector SPDR ETF

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.